Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction Kassandra P. NealonNikhil SobtiEric C. Liao Editorial 11 October 2019 Pages: 255 - 265
Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer Sylvie Rodrigues-FerreiraAngie MolinaClara Nahmias Review 12 October 2019 Pages: 267 - 273
Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials Xiaoying QianZhian LiWu Ding Review 12 October 2019 Pages: 275 - 285
Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment A. S. KomorowskiR. C. Pezo Review 23 October 2019 Pages: 287 - 300
Increased expression of P-cadherin is an indicator of poor prognosis in breast cancer: a systematic review and meta-analysis Sriya SridharChristabelle RajeshShama Prasada Kabekkodu Review 29 October 2019 Pages: 301 - 313
Risk stratification system for groups with a low, intermediate, and high risk of subsequent distant metastasis and death following isolated locoregional recurrence of breast cancer Young Joo LeeHeeseung ParkJong Won Lee Preclinical Study 23 October 2019 Pages: 315 - 324
Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment Radoslaw BednarekAnna SelmiMaria Swiatkowska Preclinical study Open access 24 October 2019 Pages: 325 - 335
Molecular determinants of drug response in TNBC cell lines Nathan M. MerrillEric J. LachaczMatthew B. Soellner Preclinical study 26 October 2019 Pages: 337 - 347
Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer Yousif A. KaririChitra JosephEmad A. Rakha Preclinical study Open access 02 November 2019 Pages: 349 - 357
Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast Debarpan MitraSayantan BhattacharyyaNabendu Murmu Preclinical study 04 November 2019 Pages: 359 - 370
Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients Hugo HerrscherMichel VeltenThierry Petit Clinical Trial 14 October 2019 Pages: 371 - 376
The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study Donna L. BerryTraci M. BlonquistTari A. King Clinical trial 14 October 2019 Pages: 377 - 385
Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies Dimitri CareneAlicia Tran-DienStefan Michiels Clinical trial 16 October 2019 Pages: 387 - 401
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients Malgorzata Banys-PaluchowskiKarin Milde-LangoschVolkmar Müller Clinical trial 23 October 2019 Pages: 403 - 414
Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines? Youngjee ChoiKatherine C. SmithClaire F. Snyder Clinical trial 24 October 2019 Pages: 415 - 424
Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgery Annika FunkJörg HeilMichael Golatta Clinical trial 25 October 2019 Pages: 425 - 433
Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer Toshiaki IwaseTakafumi SangaiMasayuki Ohtsuka Epidemiology 16 October 2019 Pages: 435 - 443
Association of lifestyle and clinical characteristics with receipt of radiotherapy treatment among women diagnosed with DCIS in the NIH-AARP Diet and Health Study Maeve MulloolyDiana R. WithrowGretchen L. Gierach Epidemiology 17 October 2019 Pages: 445 - 457
Body mass index and risk of breast cancer molecular subtypes in Korean women: a case–control study Seok Hun JeongYoonsuk AnSue K. Park Epidemiology 18 October 2019 Pages: 459 - 470
Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults Hiten NaikBonnie LeungCheryl Ho Epidemiology 19 October 2019 Pages: 471 - 477
Patient-reported cosmetic satisfaction and the long-term association with quality of life in irradiated breast cancer patients M. C. T. BatenburgM. L. Gregorowitschthe UMBRELLA study group Epidemiology Open access 24 October 2019 Pages: 479 - 489
Association of depression and anxiety disorder with the risk of mortality in breast cancer: A National Health Insurance Service study in Korea Eun-Jung ShimJong Won LeeYoo Seok Kim Epidemiology 31 October 2019 Pages: 491 - 498
The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk Shang CaoFeiran WeiMing Wu Epidemiology 06 November 2019 Pages: 499 - 509
Flat epithelial atypia: are we being too aggressive? Ashley DiPasqualeSveta SilvermanLashan Peiris Epidemiology 07 November 2019 Pages: 511 - 517
Authors’ reply to the comment “Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism” Glauco Akelinghton Freire VitielloMarla Karine AmaranteMaria Angelica Ehara Watanabe Rebuttal letter 28 September 2019 Pages: 519 - 520
Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1 Lufeng ZhengXiaoman LiTao Xi Correction 26 October 2019 Pages: 521 - 522
